One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
Nabijon YuldashevRepublican Specialized Center of Cardiology, Tashkent, UzbekistanRobert GilCentral Clinical Hospital of the Internal Affairs and Administration Ministry, Warsaw, PolandR. D. KurbanovRepublican Specialized Center of Cardiology, Tashkent, Uzbekistan
ABI
Аннотация
The aim of this study was to evaluate the immediate and long-term (12 months) clinical and angiographic efficacy of myocardial revascularization using Absorb GT1 Bioresorbable Vascular Scaffold (BVS) in comparison to second-generation drugeluting stent (DES) in patients with various forms of coronary artery disease (CAD).
Ҳали таржима қилинмаган
Мавзулар
Идентификаторлар
Иқтибослар ва манбалар
0 та иқтибос10 та фойдаланилган манба